Search

Search Results

• SUBTYPE DISTRIBUTION AND MUTATION SPECTRUM THALASSEMIA IN CHILDREN UNDER 10 YEARS IN NORTHERN VIETNAM

  Ngoc Dung Nguyen, Ha Thanh Nguyen, Thi Chi Nguyen, Thi Nguyet Anh Phi, Thi Thu Ha Nguyen, Thi Thu Huyen Le, Phuong Linh Hoang, Duc Binh Vu

  e2026002

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.002

  1127

  PDF: 795

  Html: 413

• THE UTILITY OF BLOOD AND BONE MARROW FILMS AND TREPHINE BIOPSY SECTIONS IN THE DIAGNOSIS OF PARASITIC INFECTIONS

  Clare Miller, Barbara Bain

  e2015039

  2015-05-26

  https://doi.org/10.4084/mjhid.2015.039

  1977

  PDF: 1242

  HTML: 21642

• The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis

  Maria Pina Dore, Giovanni Mario Pes, Sandro Mereu, Jessica Piroddu, Lorenzo Cavagna, Gian Luca Erre

  e2024056

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.056

  1302

  PDF: 910

  HTML: 125

• EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA

  Eduardo Magalhães Rego, Rafael Henriques Jácomo

  e2011049

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.049

  2826

  PDF: 1144

  HTML: 2586

• THALASSAEMIA INTERMEDIA : AN UPDATE

  Ali Taher, Khaled M. Musallam, Maria Domenica Cappellini

  e2009004

  2009-08-17

  1151

  PDF: 480

  HTML: 9481

• VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE

  Ashraf Tawfik Soliman

  e2013057

  2013-09-02

  https://doi.org/10.4084/mjhid.2013.057

  2892

  PDF: 1166

  HTML: 2691

• ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes

  r. Salam Al-Kindi

  e2023002

  2022-12-31

  https://doi.org/10.4084/MJHID.2023.002

  1644

  PDF: 1335

  HTML: 558

• PROGNOSTIC VALUE OF PROTEASE ACTIVATED RECEPTOR-1 IN EGYPTIAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

  Adel Abd Elhaleim Hagag

  e2014029

  2014-04-06

  https://doi.org/10.4084/mjhid.2014.029

  1467

  PDF: 874

  HTML: 2382

• A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA

  Michele Baccarani, Fabrizio Pane

  e2014010

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.010

  3351

  PDF: 1429

  HTML: 4163

• THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA

  Luca Laurenti

  e2013027

  2013-04-10

  https://doi.org/10.4084/mjhid.2013.027

  2378

  PDF: 1103

  HTML: 2767

• IMPACT OF MULTIPLEX PCR IN REDUCING THE RISK OF RESIDUAL TRANSFUSION-TRANSMITTED HUMAN IMMUNODEFICIENCY AND HEPATITIS B AND C VIRUSES IN BURKINA FASO

  Arzouma Paul YOODA, Serge Theophile SOUBEIGA, Kompingnin Yacouba NEBIE, Birama DIARRA, Salam SAWADOGO, Abdoul Karim OUATTARA, Dorcas OBIRI-YEBOAH, Albert Theophane YONLI, Issoufou TAO, Pegdwende Abel SORGHO, Honorine DAHOUROU, Jacques SIMPORE

  e2018041

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.041

  2618

  PDF: 1054

  HTML: 368

• Protein S deficiency with recurrent thromboembolism in a patient with hemoglobin H disease following splenectomy

  Kun Yang

  e2024017

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.017

  696

  PDF: 1120

  HTML: 141

• HEALTH-RELATED QUALITY OF LIFE IN THAI CHILDREN WITH THALASSEMIA AS EVALUATED BY PEDSQL AND EQ-5D-Y: A SINGLE CENTER EXPERIENCE

  Pacharapan Surapolchai, Phakatip Sinlapamongkolkul

  e2020036

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.036

  1675

  PDF: 1230

  HTML: 388

• NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES

  Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso

  e2010021

  2010-08-11

  https://doi.org/10.4084/mjhid.2010.021

  2124

  PDF: 1985

  HTML: 811

• PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.

  Ariel Koren, Lora Profeta, Luci Zalman, Haya Palmor, Carina Levin, Ronit Bril Zamir, Stavit Shalev, Orna Blondheim

  e2014012

  2014-02-17

  https://doi.org/10.4084/mjhid.2014.012

  3325

  PDF: 1430

  HTML: 11869

• Ph-negative chronic myeloproliferative neoplasm (primary myelofibrosis)– as one of the reasons of the Budd-Chiari syndrome.

  Maria Dmitrievna Sanatko

  e2012047

  2012-06-30

  https://doi.org/10.4084/mjhid.2012.047

  2552

  PDF: 925

  HTML: 725

  Untitled: 277

• Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients

  Alfredo Marzano, Andrea Marengo, Michela di Fonzo, Antonella Ferrari, Bruno Monarca, Gianfranco delle Fave, Massimo Marignani

  e2010035

  2010-12-13

  https://doi.org/10.4084/mjhid.2010.035

  1062

  PDF: 607

  HTML: 2231

  Cover Letter: 240